NM_000507.4:c.490G>A
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_000507.4(FBP1):c.490G>A(p.Gly164Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000192 in 1,614,008 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000507.4 missense
Scores
Clinical Significance
Conservation
Publications
- fructose-1,6-bisphosphatase deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia, Genomics England PanelApp, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000507.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| FBP1 | NM_000507.4 | MANE Select | c.490G>A | p.Gly164Ser | missense | Exon 4 of 7 | NP_000498.2 | ||
| FBP1 | NM_001127628.2 | c.490G>A | p.Gly164Ser | missense | Exon 5 of 8 | NP_001121100.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| FBP1 | ENST00000375326.9 | TSL:1 MANE Select | c.490G>A | p.Gly164Ser | missense | Exon 4 of 7 | ENSP00000364475.5 | ||
| FBP1 | ENST00000415431.5 | TSL:2 | c.490G>A | p.Gly164Ser | missense | Exon 5 of 8 | ENSP00000408025.1 | ||
| FBP1 | ENST00000648117.1 | c.295G>A | p.Gly99Ser | missense | Exon 3 of 6 | ENSP00000498145.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152208Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000240 AC: 6AN: 250320 AF XY: 0.0000369 show subpopulations
GnomAD4 exome AF: 0.0000205 AC: 30AN: 1461800Hom.: 0 Cov.: 33 AF XY: 0.0000193 AC XY: 14AN XY: 727204 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152208Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74350 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Fructose-biphosphatase deficiency Pathogenic:7
Variant summary: FBP1 c.490G>A (p.Gly164Ser) results in a non-conservative amino acid change located in the Fructose-1-6-bisphosphatase class I, N-terminal domain (IPR033391) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 2.4e-05 in 250320 control chromosomes. c.490G>A has been reported in the literature in multiple homozygous and compound heterozygous individuals affected with Fructose-biphosphatase deficiency (e.g. Moon_2011, Santer_2016, Li_2017). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function and found the variant results in approximately 25% activity versus the wildtype protein (e.g. Moon_2011). The following publications have been ascertained in the context of this evaluation (PMID: 27101822, 20096900, 28420223). ClinVar contains an entry for this variant (Variation ID: 868). Based on the evidence outlined above, the variant was classified as pathogenic.
Absent from controls (or at extremely low frequency if recessive) in Genome Aggregation Database, Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium.;Multiple lines of computational evidence support a deleterious effect on the gene or gene product (conservation, evolutionary, splicing impact, etc).;For recessive disorders, detected in trans with a pathogenic variant.;Patient's phenotype or family history is highly specific for a disease with a single genetic etiology.
This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 164 of the FBP1 protein (p.Gly164Ser). This variant is present in population databases (rs121918188, gnomAD 0.01%). This missense change has been observed in individual(s) with fructose-1,6-bisphosphatase deficiency (PMID: 9382095, 20096900, 25601412, 27101822). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 868). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt FBP1 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects FBP1 function (PMID: 9382095, 20096900). For these reasons, this variant has been classified as Pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at